DNA Sequencing Market, by Product Type (Consumables, Instruments, and Services), by Technology (Sanger Sequencing, Next-Generation Sequencing, Third- Generation DNA Sequencing, and Others), by Application (Oncology, Reproductive Health, Clinical Investiga

DNA Sequencing Market, by Product Type (Consumables, Instruments, and Services), by Technology (Sanger Sequencing, Next-Generation Sequencing, Third- Generation DNA Sequencing, and Others), by Application (Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Metagenomics, Epidemiology & Drug Development, and Others), by End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Clinical Research, and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

DNA sequencing is a process of determining the sequence of nucleic acids (the order of nucleotides in DNA). This includes any method or technique used to determine the order of the four bases: adenine, guanine, cytosine, and thymine. There are two types of DNA sequencing: shotgun and high-throughput. Shotgun (Sanger) sequencing is the more traditional approach, which is designed for sequencing the entire chromosomes or long DNA strands with more than 1,000 base pairs. High-throughput sequencing is also known as next-generation sequencing (NGS).

DNA sequencing is a process that is used to determine the order of nucleotides in a specific DNA molecule. DNA sequencing is used for a range of purposes, including diagnosis and treatment of diseases.

Market Dynamics

Increasing adoption of organic growth strategies, such as product launches by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in May 2020, F. Hoffmann-La Roche Ltd, a pharmaceutical company, announced the launch of a new exome and custom KAPA target enriched portfolio for translational and clinical research applications in the sequencing. This new product provided researchers with a streamlined and fully automatable sample preparation workflow which decreased the hands-on and turnaround time.

The increasing adoption of organic growth strategies such as product launches by key players in the market to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in November 2021, Pacific Biosciences of California, Inc., a U.S.-based biotechnology company, announced the launch of HiFiViral SARS-CoV-2 Kit, a kit that provided solutions for COVID-19 surveillance, which helped public health laboratories in identifying new SARS-CoV-2 variants and detected all variants circulating within a population.

Key features of the study:

• This report provides in-depth analysis of the global DNA sequencing market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global DNA sequencing market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer Genomics, QIAGEN, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Macrogen, Inc., Abbott, PacBio, Zymo Research Corporation, Oxford Nanopore Technologies plc, Tecan Trading AG, Hamilton Company, ZS Genetics, Inc. LI-COR, Inc.
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global DNA sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global DNA sequencing market

Detailed Segmentation:

• Global DNA Sequencing Market, By Product Type:
• Consumables
• Instruments
• Services
• Global DNA Sequencing Market, By Technology:
• Sanger Sequencing
• Next-Generation Sequencing
• Third- Generation DNA Sequencing
• Others
• Global DNA Sequencing Market, By Application:
• Oncology
• Reproductive Health
• Clinical Investigation
• Agrigenomics & Forensics
• Metagenomics, Epidemiology & Drug Development
• Others
• Global DNA Sequencing Market, By End User:
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Clinical Research
• Others
• Global DNA Sequencing Market, By Region:
• North America
• By Country:
• U.S.
• Canada
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country:
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country:
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region:
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Thermo Fisher Scientific, Inc.*
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Illumina, Inc.
• PerkinElmer Genomics
• QIAGEN
• Agilent Technologies, Inc.
• F. Hoffmann-La Roche Ltd
• Macrogen, Inc.
• Abbott
• PacBio
• Zymo Research Corporation
• Oxford Nanopore Technologies plc
• Tecan Trading AG
• Hamilton Company
• ZS Genetics, Inc.
• LI-COR, Inc.

“*” marked represents similar segmentation in other categories in the respective section.